{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:25:12Z","timestamp":1786469112319,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360461"],"award-info":[{"award-number":["82360461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Talent Project of First Affiliated Hospital of Kunming Medical","award":["2023535Q11"],"award-info":[{"award-number":["2023535Q11"]}]},{"name":"Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Foundation","award":["202001AY070001-144"],"award-info":[{"award-number":["202001AY070001-144"]}]},{"name":"Yunnan Provincial Clinical Key Specialty of Thoracic Surgery","award":["300067"],"award-info":[{"award-number":["300067"]}]},{"name":"Yunnan Fundamental Research Projects","award":["202301AT070143"],"award-info":[{"award-number":["202301AT070143"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10495-025-02177-y","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:58:14Z","timestamp":1763751494000},"page":"3069-3086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ACTG1 mediates cisplatin resistance in NSCLC through induction of mitochondrial fragmentation"],"prefix":"10.1007","volume":"30","author":[{"given":"Minghua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2177_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2177_CR2","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s12539-018-0300-9","volume":"10","author":"S Liu","year":"2018","unstructured":"Liu S, Wang X, Qin W, Genchev GZ, Lu H (2018) Transcription factors contribute to differential expression in cellular pathways in lung adenocarcinoma and lung squamous cell carcinoma. Interdiscip Sci Comput Life Sci 10:836\u2013847","journal-title":"Interdiscip Sci Comput Life Sci"},{"key":"2177_CR3","first-page":"270","volume":"3","author":"C Zhou","year":"2014","unstructured":"Zhou C (2014) Lung cancer molecular epidemiology in China: recent trends. Transl Lung Cancer Res 3:270","journal-title":"Transl Lung Cancer Res"},{"key":"2177_CR4","first-page":"46","volume":"77","author":"O Molinier","year":"2020","unstructured":"Molinier O, Goupil F, Debieuvre D et al (2020) Five-year survival and prognostic factors according to histology in 6101 non-small-cell lung cancer patients. Respir Med Res 77:46\u201354","journal-title":"Respir Med Res"},{"key":"2177_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","volume":"10","author":"Q Huang","year":"2025","unstructured":"Huang Q, Li Y, Huang Y et al (2025) Advances in molecular pathology and therapy of non-small cell lung cancer. Signal Transduct Target Ther 10:186","journal-title":"Signal Transduct Target Ther"},{"key":"2177_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41416-020-01069-z","volume":"123","author":"M Evison","year":"2020","unstructured":"Evison M, Limited AU (2020) The current treatment landscape in the UK for stage III NSCLC. Br J Cancer 123:3\u20139","journal-title":"Br J Cancer"},{"key":"2177_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","volume":"10","author":"LE Hendriks","year":"2024","unstructured":"Hendriks LE, Remon J, Faivre-Finn C et al (2024) Non-small-cell lung cancer. Nat Rev Dis Primers 10:71","journal-title":"Nat Rev Dis Primers"},{"key":"2177_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01121-2","volume":"14","author":"U Majeed","year":"2021","unstructured":"Majeed U, Manochakian R, Zhao Y, Lou Y (2021) Targeted therapy in advanced non-small cell lung cancer: current advances and future trends. J Hematol Oncol 14:1\u201320","journal-title":"J Hematol Oncol"},{"key":"2177_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-023-06088-1","volume":"14","author":"Z Jin","year":"2023","unstructured":"Jin Z, Zhao L, Chang Y et al (2023) Crtac1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression. Cell Death Dis 14:563","journal-title":"Cell Death Dis"},{"key":"2177_CR10","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.3390\/ijms22168885","volume":"22","author":"J Kryczka","year":"2021","unstructured":"Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzezia\u0144ska-Lasota E (2021) Molecular mechanisms of chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J Mol Sci 22:8885","journal-title":"Int J Mol Sci"},{"key":"2177_CR11","doi-asserted-by":"publisher","first-page":"25372","DOI":"10.1021\/acsnano.4c02940","volume":"18","author":"F Ding","year":"2024","unstructured":"Ding F, Zhou M, Ren Y et al (2024) Mitochondrial extracellular vesicles: a promising avenue for diagnosing and treating lung diseases. ACS Nano 18:25372\u201325404","journal-title":"ACS Nano"},{"key":"2177_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13046-024-03168-8","volume":"43","author":"W Chen","year":"2024","unstructured":"Chen W, Yang K-B, Zhang Y-Z et al (2024) Synthetic lethality of combined ULK1 defection and p53 restoration induce pyroptosis by directly upregulating GSDME transcription and cleavage activation through ROS\/NLRP3 signaling. J Exp Clin Cancer Res 43:248","journal-title":"J Exp Clin Cancer Res"},{"key":"2177_CR13","doi-asserted-by":"publisher","first-page":"155880","DOI":"10.1016\/j.phymed.2024.155880","volume":"132","author":"X Pu","year":"2024","unstructured":"Pu X, Zhang Q, Liu J et al (2024) Ginsenoside Rb1 ameliorates heart failure through DUSP-1-TMBIM-6-mediated mitochondrial quality control and gut flora interactions. Phytomedicine 132:155880","journal-title":"Phytomedicine"},{"key":"2177_CR14","doi-asserted-by":"publisher","first-page":"754235","DOI":"10.3389\/fnut.2021.754235","volume":"8","author":"L Chen","year":"2021","unstructured":"Chen L, Tian Q, Shi Z, Qiu Y, Lu Q, Liu C (2021) Melatonin alleviates cardiac function in sepsis-caused myocarditis via maintenance of mitochondrial function. Front Nutr 8:754235","journal-title":"Front Nutr"},{"key":"2177_CR15","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1002\/ptr.8177","volume":"38","author":"X Chang","year":"2024","unstructured":"Chang X, Zhang Q, Huang Y et al (2024) Quercetin inhibits necroptosis in cardiomyocytes after ischemia\u2013reperfusion via DNA-PKcs-SIRT5-orchestrated mitochondrial quality control. Phytother Res 38:2496\u20132517","journal-title":"Phytother Res"},{"key":"2177_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2019.03.009","volume":"135","author":"A Cruz-Berm\u00fadez","year":"2019","unstructured":"Cruz-Berm\u00fadez A, Laza-Briviesca R, Vicente-Blanco RJ et al (2019) Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1\u03b1 in NSCLC which can be overcome by OXPHOS inhibition. Free Radic Biol Med 135:167\u2013181","journal-title":"Free Radic Biol Med"},{"key":"2177_CR17","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.3390\/ijms20143384","volume":"20","author":"V Cocetta","year":"2019","unstructured":"Cocetta V, Ragazzi E, Montopoli M (2019) Mitochondrial involvement in cisplatin resistance. Int J Mol Sci 20:3384","journal-title":"Int J Mol Sci"},{"key":"2177_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Angeli JPF, Bayir H et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273\u2013285","journal-title":"Cell"},{"key":"2177_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.chembiol.2020.03.013","volume":"27","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X (2020) The chemistry and biology of ferroptosis. Cell Chem Biol 27:365\u2013375","journal-title":"Cell Chem Biol"},{"key":"2177_CR20","doi-asserted-by":"publisher","first-page":"794735","DOI":"10.3389\/fonc.2021.794735","volume":"11","author":"W-J Liu","year":"2022","unstructured":"Liu W-J, Pan P-y, Sun Y et al (2022) Deferoxamine counteracts cisplatin resistance in A549 lung adenocarcinoma cells by increasing vulnerability to glutamine deprivation-induced cell death. Front Oncol 11:794735","journal-title":"Front Oncol"},{"key":"2177_CR21","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/jcb.26301","volume":"119","author":"X Dong","year":"2018","unstructured":"Dong X, Han Y, Sun Z, Xu J (2018) Actin gamma 1, a new skin cancer pathogenic gene, identified by the biological feature-based classification. J Cell Biochem 119:1406\u20131419","journal-title":"J Cell Biochem"},{"key":"2177_CR22","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S197844","author":"Y Yan","year":"2019","unstructured":"Yan Y, Xu H, Zhang L et al (2019) RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma. OncoTargets Ther. https:\/\/doi.org\/10.2147\/OTT.S197844","journal-title":"OncoTargets Ther"},{"key":"2177_CR23","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/jog.14353","volume":"46","author":"S Chen","year":"2020","unstructured":"Chen S, Wang X, Yuan J, Deng C, Xie X, Kang J (2020) Reduced levels of actin gamma 1 predict poor prognosis in ovarian cancer patients. J Obstet Gynaecol Res 46:1827\u20131834","journal-title":"J Obstet Gynaecol Res"},{"key":"2177_CR24","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1007\/s11064-020-03081-4","volume":"45","author":"C Zhou","year":"2020","unstructured":"Zhou C, Jiang X, Liang A et al (2020) COX10-AS1 facilitates cell proliferation and inhibits cell apoptosis in glioblastoma cells at post-transcription level. Neurochem Res 45:2196\u20132203","journal-title":"Neurochem Res"},{"key":"2177_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/sjg.sjg_356_21","volume":"28","author":"Y Tang","year":"2022","unstructured":"Tang Y, Peng X, Huang X, Li J (2022) Actin gamma 1 is a critical regulator of pancreatic ductal adenocarcinoma. Saudi J Gastroenterol 28:239\u2013246","journal-title":"Saudi J Gastroenterol"},{"key":"2177_CR26","doi-asserted-by":"publisher","first-page":"597835","DOI":"10.3389\/fcell.2020.597835","volume":"8","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Fujii T, Sakai H (2020) The relationship between actin cytoskeleton and membrane transporters in cisplatin resistance of cancer cells. Front Cell Dev Biol 8:597835","journal-title":"Front Cell Dev Biol"},{"key":"2177_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12575-023-00228-9","volume":"26","author":"H Wang","year":"2024","unstructured":"Wang H, Min J, Ding Y et al (2024) MBD3 promotes epithelial-mesenchymal transition in gastric cancer cells by upregulating ACTG1 via the PI3K\/AKT pathway. Biol Proced Online 26:1","journal-title":"Biol Proced Online"},{"key":"2177_CR28","doi-asserted-by":"publisher","first-page":"e2739","DOI":"10.1038\/cddis.2017.61","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Zhang Y, Wu H et al (2017) Mir-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis. Cell Death Dis 8:e2739\u2013e2739","journal-title":"Cell Death Dis"},{"key":"2177_CR29","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1089\/dna.2021.0416","volume":"40","author":"L Xiao","year":"2021","unstructured":"Xiao L, Peng H, Yan M, Chen S (2021) Silencing ACTG1 expression induces prostate cancer epithelial mesenchymal transition through MAPK\/ERK signaling pathway. DNA Cell Biol 40:1445\u20131455","journal-title":"DNA Cell Biol"},{"key":"2177_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"D Li","year":"2020","unstructured":"Li D, Li Y (2020) The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther 5:1\u201310","journal-title":"Signal Transduct Target Ther"},{"key":"2177_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su Z, Yang Z, Xu Y, Chen Y, Yu Q (2015) Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 14:1\u201314","journal-title":"Mol Cancer"},{"key":"2177_CR32","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.18632\/aging.205408","volume":"16","author":"S Han","year":"2024","unstructured":"Han S, Yang X, Zhuang J et al (2024) \u03b1-Hederin promotes ferroptosis and reverses cisplatin chemoresistance in non-small cell lung cancer. Aging (Albany NY) 16:1298","journal-title":"Aging (Albany NY)"},{"key":"2177_CR33","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.drup.2023.100985","volume":"70","author":"J Wang","year":"2023","unstructured":"Wang J, Zeng L, Wu N et al (2023) Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resist Updat 70:100985","journal-title":"Drug Resist Updat"},{"key":"2177_CR34","doi-asserted-by":"publisher","first-page":"e48686","DOI":"10.15252\/embr.201948686","volume":"21","author":"H Han","year":"2020","unstructured":"Han H, Tan J, Wang R et al (2020) PINK1 phosphorylates Drp1S616 to regulate mitophagy-independent mitochondrial dynamics. EMBO Rep 21:e48686","journal-title":"EMBO Rep"},{"key":"2177_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12032-023-02237-w","volume":"41","author":"R Fu","year":"2023","unstructured":"Fu R, Zhao B, Chen M et al (2023) Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy. Med Oncol 41:9","journal-title":"Med Oncol"},{"key":"2177_CR36","first-page":"323","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Yan H, Xu X, Liu H, Wu C, Zhao L (2020) Erastin\/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2\/xCT pathway. Oncol Lett 19:323\u2013333","journal-title":"Oncol Lett"},{"key":"2177_CR37","doi-asserted-by":"publisher","first-page":"101051","DOI":"10.1016\/j.tranon.2021.101051","volume":"14","author":"R Suresh","year":"2021","unstructured":"Suresh R, Diaz RJ (2021) The remodelling of actin composition as a hallmark of cancer. Transl Oncol 14:101051","journal-title":"Transl Oncol"},{"key":"2177_CR38","first-page":"7611","volume":"17","author":"CG Lee","year":"2018","unstructured":"Lee CG, Jang J, Jin HS (2018) A novel missense mutation in the ACTG1 gene in a family with congenital autosomal dominant deafness: a case report. Mol Med Rep 17:7611\u20137617","journal-title":"Mol Med Rep"},{"key":"2177_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12957-024-03417-2","volume":"22","author":"H Xiao","year":"2024","unstructured":"Xiao H, Chen H, Zhang L et al (2024) Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma. World J Surg Oncol 22:152","journal-title":"World J Surg Oncol"},{"key":"2177_CR40","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1158\/0008-5472.CAN-18-4080","volume":"79","author":"Y-C Chang","year":"2019","unstructured":"Chang Y-C, Chiou J, Yang Y-F et al (2019) Therapeutic targeting of aldolase A interactions inhibits lung cancer metastasis and prolongs survival. Cancer Res 79:4754\u20134766","journal-title":"Cancer Res"},{"key":"2177_CR41","doi-asserted-by":"publisher","first-page":"e54193","DOI":"10.1371\/journal.pone.0054193","volume":"8","author":"MP Barr","year":"2013","unstructured":"Barr MP, Gray SG, Hoffmann AC et al (2013) Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. PLoS ONE 8:e54193","journal-title":"PLoS ONE"},{"key":"2177_CR42","doi-asserted-by":"publisher","first-page":"879317","DOI":"10.3389\/fphar.2022.879317","volume":"13","author":"Z Nie","year":"2022","unstructured":"Nie Z, Chen M, Gao Y et al (2022) Ferroptosis and tumor drug resistance: current status and major challenges. Front Pharmacol 13:879317","journal-title":"Front Pharmacol"},{"key":"2177_CR43","doi-asserted-by":"publisher","first-page":"1402514","DOI":"10.3389\/fphar.2024.1402514","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen R, Zhu S, Zhao R et al (2024) Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma. Front Pharmacol 15:1402514","journal-title":"Front Pharmacol"},{"key":"2177_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/lifemeta\/loac035","volume":"1","author":"J Guo","year":"2022","unstructured":"Guo J, Zhou Y, Liu D et al (2022) Mitochondria as multifaceted regulators of ferroptosis. Life Metab 1:134\u2013148","journal-title":"Life Metab"},{"key":"2177_CR45","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.3390\/ijms20143415","volume":"20","author":"K Wang","year":"2019","unstructured":"Wang K, Chen B, Yin T et al (2019) N-methylparoxetine blocked autophagic flux and induced apoptosis by activating ROS-MAPK pathway in non-small cell lung cancer cells. Int J Mol Sci 20:3415","journal-title":"Int J Mol Sci"},{"key":"2177_CR46","doi-asserted-by":"publisher","first-page":"1360638","DOI":"10.3389\/fonc.2024.1360638","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, Li X, Li J (2024) Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies. Front Oncol 14:1360638","journal-title":"Front Oncol"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02177-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02177-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:03:38Z","timestamp":1764590618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02177-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":46,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2177"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02177-y","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"24 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no declarations of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Xenograft experiment conducted under approval of The First Affiliated Hospital of Kunming Medical University Ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}}]}}